Systematic ReviewPublished 12 October 2026Imaging biomarkers related to 18F-FDG PET/CT for predicting microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysisZhigang Li · Ke Gong · Ning LiuFrontiers in Oncologydoi 10.3389/fonc.2026.1948193
ReviewPublished 7 October 2026Liver-resident cellular determinants of oncolytic virotherapy in hepatocellular carcinoma: viral susceptibility and spatial immune remodelingDing Hu · Qiong WangFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1959317
Original ResearchPublished 7 October 2026Relationships among heart rate variability, sleep disturbances, and fatigue in patients undergoing interventional therapy for hepatocellular carcinomaBo Xie · Yaqin Yun · Zhouhua Xu · Yue Meng · Mingxuan Peng · Yuqiao Xie · Huiyun Zhou · Hong Xu · Lingjie XuFrontiers in Physiologydoi 10.3389/fphys.2026.1923785
Case ReportPublished 6 October 2026Case Report: Long term multimodality treatment of canine hepatocellular carcinoma with serial monitoring of serum alpha-fetoproteinTae-Jung Dan · Cheol-Ho Yang · Yeon-Jin Kim · Min-Hee Kang · Mi-Ae Kang · Kwang-Sup Lee · Hee-Myung ParkFrontiers in Veterinary Sciencedoi 10.3389/fvets.2026.1942682
ReviewPublished 5 October 2026Multimodal biomarkers for early detection and immunotherapy assessment in hepatocellular carcinoma: integrating liquid biopsy, AI-based imaging and tumor immune profilingYuli Zhao · Xiaolei Chen · Hanyu ZhaoFrontiers in Geneticsdoi 10.3389/fgene.2026.1951687
Original ResearchPublished 1 October 2026Serum exosomal DDX17 in the diagnosis and action mechanism of hepatocellular carcinomaDefa Huang · Minghong Zhao · Meijin Liu · Tao Chen · Zihao Chen · Yuhuan Xie · Haiyang Yu · Shuqian Zhong · Junyun Huang · Dingyu RaoFrontiers in Cell and Developmental Biologydoi 10.3389/fcell.2026.1897138
Original ResearchPublished 29 September 2026NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trialRuihong Dai · Facheng Lu · Weibing Leng · Qing He · Wenhao Guo · Tao Hai · Chang LiuFrontiers in Gastroenterologydoi 10.3389/fgstr.2026.1926294
Original ResearchPublished 29 September 2026Genetic evidence and multi-omics characterization of DEHP-relevant detoxification and metabolic heterogeneity in hepatocellular carcinomaZeyang Fan · Guoqing Zhang · Letian Ren · Wence ZhouFrontiers in Toxicologydoi 10.3389/ftox.2026.1925431
PerspectivePublished 18 August 2026Geranylgeranoic acid, toll-like receptor 4, and pyroptosis-related signaling in hepatocellular carcinoma: a hypothesis-generating perspectiveYuki TabataOncology Reviewsdoi 10.3389/or.2026.1882953
Original ResearchPublished 18 August 2026Predictive value of an AI model integrating MRI radiomics and clinical features for early recurrence of hepatocellular carcinoma prior to radiofrequency ablationBeibei Zhang · Wenhua Li · Jing Tang · Ruixin Li · Xiao Wang · Xiaoming Liu · Tianran LiFrontiers in Radiologydoi 10.3389/fradi.2026.1824091
Systematic ReviewPublished 19 March 2026Meta-analysis of efficacy and safety of Yttrium-90 radioembolization (TARE) in the treatment of advanced hepatocellular carcinomaHongyin Lin · Quanhui TanFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1784215
